A woman's health is intricately linked to her menstrual cycle, which is an important sign of her overall well-being. Throughout puberty and menopause, hormonal changes affect not only fertility but also mood, energy, and long-term health. A normal cycle usually indicates balance, whereas abnormalities may suggest problems such as PCOS, endometriosis, or thyroid disease.

Our bodies do not always work in a perfect clockwork operation and unexpected vaginal bleeding can often confused us. Is it a mere spotting? A normal period? A symptom of something more concerning? Differences between spotting, menstrual bleeding, and intermenstrual bleeding should be understood is crucial for maintaining reproduction health.

Here is a short guide to help you differentiate while you are confused.

Spotting

Spotting is vaginal bleeding that doesn't happen as part of your regular menstrual period. It commonly manifests as fine droplets or smears of blood on clothing or toilet tissue. The intensity of the blood ranges from deep red (recent blood) to pink (having cervical mucus mixed in it) or brown (older, oxidized blood). Spotting is not very much and can't be seen in a way that needs either a tampon or a pad to absorb.

Common Causes of Spotting

Spotting is caused by numerous factors, and in the majority of instances, it is nothing to worry about. Some frequent causes are:

Hormonal Birth Control Transitions: New birth control technique, for instance, birth control pills, IUDs containing hormones, or implants, results in temporary spotting as the body adapts.

Ovulation Bleeding: A few individuals get spotting light around the time of ovulation as a result of hormonal changes. It normally happens in the mid-cycle and could be followed by slight cramping.

Cervical Ectropion: A harmless condition when cells from the inside of the cervical canal migrate to the outer cervix, causing the outer cervix to become more sensitive and prone to faint bleeding on coitus or physical activity.

Early Pregnancy (Implantation Bleeding): 15–25% of pregnant women experience light spotting around 10–14 days post-conception, which is confused with an early period.

When to See a Doctor

Spotting is usually harmless, but it's best to consult a doctor if:

• It continues after a few months of initiating new birth control
• Is accompanied by pelvic pain or abnormal discharge
• Occurs after frequent intercourse
• Occurs during pregnancy and is not verified as implantation bleeding

Menstrual Bleeding

There is a time, also known as a period or menstruation, when the uterine lining sheds due to changing hormone levels. It would last for approximately 2-7 days and is heavier initially. The hue and texture of period blood shift during the menstrual cycle:

Red: New active bleeding at the start of a period

Brown or dark red: Older, slower blood in leaving the uterus

Clots: It's normal to have small clots, but bigger clots may be a sign of heavy menstrual bleeding (HMB)

Why You Have a Period Essentially?

Menstruation is a part of the reproductive cycle, and it happens around every 21–35 days. When there's no pregnancy after ovulation, hormone levels fall, causing the uterine lining to be shed.

Signs Your Period May Be Abnormal

Though periods differ in different people, there are some signs that point towards probable underlying conditions:

• Prolonged bleeding (longer than 7 days)
• Heavy flow necessitating pad/tampon changes every 1–2 hours
• Severe cramps that disrupt daily life
• Irregular periods or absent periods

If you have any of these, conditions such as polycystic ovary syndrome (PCOS), endometriosis, or thyroid disease may be involved, and a medical visit is in order.

Intermenstrual Bleeding

Unlike spotting, intermenstrual bleeding is heavier and unexpected between regular periods. It may be from bright red to dark brown and can contain blood clots.

Possible Causes of Bleeding Between Periods

Sexually Transmitted Infections (STIs): Chlamydia and gonorrhea can lead to inflammation and abnormal bleeding.

Pelvic Inflammatory Disease (PID): A bacterial infection of the reproductive organs and can lead to abnormal bleeding.

Uterine Fibroids or Polyps: Benign growths in the uterus that may cause unexpected bleeding.

Endometrial Hyperplasia or Cancer: In some instances, abnormal bleeding may be a sign of abnormal cell growth in the lining of the uterus.

When to See a Doctor

See a doctor if intermenstrual bleeding is:

• Frequent or persistent
• Associated with pelvic pain or discomfort
• Associated with abnormal discharge, fever or painful sex

Recognizing your body's rhythms can assist you in identifying normal versus abnormal bleeding. Monitoring your menstrual cycle through an app or calendar may flag changes that should be checked with a doctor. If you have any questions regarding abnormal bleeding, visiting your health care provider is the way to go.

A patient suffering from a rare tumour involving the sciatic nerve has made a good recovery following a successful robotic-assisted sciatic nerve schwannoma resection, marking an important milestone in advanced, minimally invasive surgical care.

Sciatic nerve schwannomas are uncommon, benign tumours that develop from the cells surrounding a nerve. Because the sciatic nerve is responsible for important motor and sensory functions of the lower limb, surgery in this region can be technically challenging. The key objective is to remove the tumour while preserving the functioning nerve fibres and minimizing the risk of neurological complications.

How Robotic Technology Can Aid Complex Surgery

The patient underwent robotic-assisted surgery under the care of a multidisciplinary surgical team. The use of robotic technology provided enhanced visualization and precise control of surgical instruments, allowing meticulous dissection around the affected nerve.

For the patient, the successful procedure meant not only removal of the tumour but also the prospect of returning to normal daily activities with preservation of neurological function.

Whenever the doctor operates on a tumour involving an important nerve, their priority is to achieve complete and safe tumour removal while protecting the nerve and its function. Robotic assistance can offer greater precision and visualization in carefully selected cases.

Following the procedure, the patient was closely monitored for neurological recovery and postoperative complications. The patient is doing well and recovering satisfactorily, providing an encouraging outcome following this complex surgical intervention.

How Minimally Invasive Techniques May Benefit Patients

Also read: H. pylori And Cancer: US Gastroenterologist Explains How A Common Stomach Infection Raises Risk

The case demonstrates how advances in surgical technology can translate into meaningful benefits for patients. Robotic-assisted surgery, when used in appropriately selected cases, can support surgeons in performing delicate procedures with enhanced precision while potentially reducing tissue trauma and facilitating recovery.

For patients diagnosed with nerve tumours, early evaluation and appropriate treatment planning are important. Symptoms can vary depending on the location and size of the tumour and may include pain, tingling, numbness, or weakness in the affected limb. Detailed imaging and neurological assessment help specialists determine the most appropriate treatment strategy.

The successful outcome reflects the importance of combining experienced surgical expertise, advanced technology, and patient-centred care. For this patient, the journey from diagnosis to successful tumour removal and recovery offers an encouraging example of what modern surgical care can achieve.

By Dr. S.K. Bala, Consultant Department of Surgical Oncology & Advanced Robotic Surgery, CMRI, CK Birla Hospitals, Kolkata

Doctors in India’s southern state of Tamil Nadu surgically removed a fully developed canine tooth from the upper eyelid region of a 16-year-old boy. They described the case as the first reported instance of an ectopic tooth in the upper part of the eye socket.

The case was reported by specialists at Aravind Eye Hospital in Madurai in the journal Ophthalmology.

What Did The Doctors Find?

The teenager visited the hospital with painless swelling of his left upper eyelid that had lasted a month. He had no history of injury to the area.

During the examination, doctors noticed two firm, whitish projections beneath the swollen area near the inner side of the upper eyelid, the experts shared in the paper.

A computed tomography (CT) scan revealed a dense structure resembling a tooth, with a crown and root, originating from the roof of the left eye socket. It extended towards the tissues in front of the orbital septum, a thin barrier separating the eyelid from the deeper eye socket, and protruded outwards with two tooth-like points on its surface.

The projections' appearance and texture raised the possibility that they were teeth. Dr. Meghana Tanwar, a medical consultant at Aravind Eye Hospital, told Live Science that they had a “fairly smooth surface and were hard on palpation.”

The doctors surgically removed the structure. Examination confirmed that it was a mature canine tooth without teratomatous elements, consistent with an ectopic tooth in the upper part of the eye socket.

Also read: Hours Of Sitting, Gaming And Binge-Watching OTT? Doctors Warn Of Blood Clot Risk In Young People

What Is An Ectopic Tooth?

An ectopic tooth develops or emerges in an abnormal location. Some remain within the mouth but appear outside their usual positions in the dental arch, while others develop outside the normal arrangement of teeth.

The latter is particularly unusual. In this teenager's case, the tooth was located in the upper orbital region rather than within the normal dental arch.

Before confirming the diagnosis, doctors considered whether the projections could be associated with a teratoma, a type of tumor that can contain different tissues, including bone and tooth tissue. They also considered whether a foreign object might be lodged in the eyelid.

Imaging and examination of the removed structure helped establish that it was a mature tooth rather than tissue associated with a teratoma.

Why Is This Case Unusual?

Read More: 3-Time Colon Cancer Survivor Reveals First Symptom She Noticed At 14

Ectopic teeth have been documented in several locations, including the nasal cavity, chin and maxillary sinus, an air-filled cavity within the cheekbone. Previous reports have also described teeth in the lower part of the eye socket.

However, the doctors said they could not find an earlier report of an ectopic tooth in the superior orbit, the upper region of the eye socket.

“To the best of our knowledge this is the first and only ectopic tooth reported in the superior orbit,” Tanwar told Live Science.

“This was a first not just for us but the world over,” she said of the case. “We were very surprised by it.”

What Causes Ectopic Teeth?

READ: Non-Healing Mouth Sores? This Silent Symptom Could Signal Oral Cancer, Warn Doctors

The doctors could not determine why the tooth developed in this unusual location.

Possible explanations for ectopic tooth development include abnormalities during development, genetic factors, infections and physical trauma. However, the cause in this case remains unknown.

Imaging did not reveal any additional ectopic teeth. Tanwar said the likelihood of the teenager developing another such tooth was low.

Pancreatic cancer is one of the cancers doctors find particularly difficult to detect early. The pancreas lies deep inside the abdomen, and early disease may cause few or vague symptoms. By the time symptoms such as jaundice, unexplained weight loss, abdominal or back pain or persistent digestive problems become apparent, the disease may already be advanced.

What Is PANXEON, The New Liquid Biopsy?

This is why the findings of a new international study on PANXEON, an investigational liquid biopsy, are attracting attention. Published in Nature Medicine, the study evaluated 1,785 people across four countries and explored whether a blood sample could identify early pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer.

The principle behind the test is relatively simple. Cancer cells release molecular material into the bloodstream. PANXEON looks at a group of tiny molecules called microRNAs, including those carried inside microscopic packages called exosomes. These molecules can provide molecular clues about what is happening in the pancreas. The test combines this microRNA signature with CA19-9, a blood marker already used in pancreatic cancer, particularly for monitoring patients, although CA19-9 alone is not suitable as a general screening test.

Also read: Dr Rachna Shroff: Indian-American Cancer Researcher Who Turned Her Diagnosis Into Advocacy

In the study, the microRNA test detected early-stage pancreatic cancer with a sensitivity of 83.8%. When combined with CA19-9, PANXEON reached 86.8% sensitivity for stage I-II disease. Importantly, false-positive rates were 3.2% among low-risk controls and 15.6% among high-risk controls. The researchers also reported that the test showed potential for identifying high-grade dysplasia in people with high-risk pancreatic cysts.

For India, this research is relevant because pancreatic cancer, although less common than several other major cancers, represents a significant clinical challenge. India’s National Cancer Registry Programme estimated about 21,000 pancreatic cancer cases in 2022. Globally, GLOBOCAN estimated more than 510,000 new cases in the same year.

Is PANXEON Ready For Routine Screening?

But there is an important caveat: PANXEON is not yet a routine screening test. There is currently no standard screening test recommended for people at average risk of pancreatic cancer. Screening is generally considered for selected high-risk individuals, such as those with significant family histories or certain inherited genetic risks.

The new findings therefore represent a promising research direction, rather than a test people should independently seek out today. A useful early-detection test must work reliably in much larger, diverse populations and demonstrate that detecting cancer earlier actually improves outcomes.

For patients and doctors, however, the concept is important. Instead of waiting for a tumour to become large enough to produce obvious symptoms or visible changes on imaging, researchers are increasingly asking whether the molecular footprints of cancer can be detected in a simple blood sample. PANXEON is one more step towards answering that question.